DuPont Decomposition

Why does HCG earn its ROE?

Breaking down Return on Equity into profitability, efficiency, and leverage.

ROE = Net Margin × Asset Turnover × Equity Multiplier

1.0% = 0.5% × 0.65 × 2.94

Latest: FY2026

Profitability

Net Margin

0.5%

3.9% →0.5%

How much profit per ₹ of revenue

Efficiency

Asset Turnover

0.65x

0.62x →0.65x

Revenue per ₹ of assets

Leverage

Equity Multiplier

2.94x

2.55x →2.94x

Assets funded by equity vs debt

Trend Analysis

ROE declined by 5.1 pp over 5 years. Driven by net margin declining (3.9% → 0.5%), leverage rising (2.55x → 2.94x).

Historical Decomposition

Last 5 years

YearRevenuePATNet MarginAsset TOLeverageROE
FY20220Cr0Cr3.9%0.622.556.2%
FY20230Cr0Cr1.8%0.722.693.4%
FY20240Cr0Cr2.5%0.703.285.8%
FY20250Cr0Cr2.0%0.633.844.8%
FY20260Cr0Cr0.5%0.652.941.0%

How to read DuPont

  • Rising ROE from margin = pricing power, operational improvement (good)
  • Rising ROE from turnover = better asset utilization (good)
  • Rising ROE from leverage = more debt, amplified risk (caution)
  • Falling ROE across all three = structural deterioration (red flag)

See DCF fair value for HCG

Combine financial quality with intrinsic value.

See Fair Value →

DuPont decomposition from audited annual financials. Factual analysis, not investment advice.